Perrigo Company PLC banner

Perrigo Company PLC
NYSE:PRGO

Watchlist Manager
Perrigo Company PLC Logo
Perrigo Company PLC
NYSE:PRGO
Watchlist
Price: 11.82 USD 1.11% Market Closed
Market Cap: $1.6B

Perrigo Company PLC
Change in Working Capital

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Perrigo Company PLC
Change in Working Capital Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Change in Working Capital CAGR 3Y CAGR 5Y CAGR 10Y
Perrigo Company PLC
NYSE:PRGO
Change in Working Capital
-$124.9m
CAGR 3-Years
N/A
CAGR 5-Years
-13%
CAGR 10-Years
N/A
Jazz Pharmaceuticals PLC
NASDAQ:JAZZ
Change in Working Capital
$18.9m
CAGR 3-Years
-59%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Avadel Pharmaceuticals PLC
NASDAQ:AVDL
Change in Working Capital
-$6.6m
CAGR 3-Years
N/A
CAGR 5-Years
5%
CAGR 10-Years
2%
G
GH Research PLC
NASDAQ:GHRS
Change in Working Capital
-$3.1m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Cosmo Pharmaceuticals NV
SIX:COPN
Change in Working Capital
-€24.6m
CAGR 3-Years
-17%
CAGR 5-Years
-61%
CAGR 10-Years
8%
Ovoca Bio PLC
LSE:OVB
Change in Working Capital
-€460k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Perrigo Company PLC
Glance View

Perrigo Company PLC, a stalwart in the pharmaceutical and healthcare sectors, has carved a niche by specializing in over-the-counter (OTC) health and wellness products. This Dublin-based company traces its origins back to 1887, in Allegan, Michigan, where it began as a modest packager of home remedies. Over the decades, Perrigo has evolved into a global powerhouse that provides affordable and quality healthcare products, distributing them across various markets around the world. Its strategy hinges on delivering effective OTC solutions and a wide array of consumer self-care products, making it a familiar presence in households seeking reliable alternatives to more expensive brand-name pharmaceuticals. Perrigo's business model is centered on offering value to both consumers and retailers. By producing generic versions of well-known drugs, it captures a significant share of the market driven by cost-conscious customers. This approach also involves collaborating with retail giants to supply their private label OTC medications, a mutually beneficial arrangement that allows retailers to offer lower-cost alternatives under their own brands while maintaining healthy margins. Beyond just OTC medications, Perrigo has expanded its offerings to include nutritional products and topical solutions, further diversifying its portfolio and revenue streams. The company's consistent investment in innovation and keen attention to regulatory compliance underscore its commitment to quality and safety, attributes that resonate well in an industry guided by trust and efficacy.

PRGO Intrinsic Value
43.73 USD
Undervaluation 73%
Intrinsic Value
Price $11.82

See Also

What is Perrigo Company PLC's Change in Working Capital?
Change in Working Capital
-124.9m USD

Based on the financial report for Dec 31, 2025, Perrigo Company PLC's Change in Working Capital amounts to -124.9m USD.

What is Perrigo Company PLC's Change in Working Capital growth rate?
Change in Working Capital CAGR 5Y
-13%

Over the last year, the Change in Working Capital growth was -67%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett